Clearmind Medicine (Clearmind Medicine) COGS-to-Revenue : 0.00 (As of Jan. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Clearmind Medicine COGS-to-Revenue?

Clearmind Medicine's Cost of Goods Sold for the three months ended in Jan. 2024 was $0.00 Mil. Its Revenue for the three months ended in Jan. 2024 was $0.00 Mil.

Clearmind Medicine's COGS to Revenue for the three months ended in Jan. 2024 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Clearmind Medicine's Gross Margin % for the three months ended in Jan. 2024 was N/A%.

Clearmind Medicine COGS-to-Revenue Historical Data

The historical data trend for Clearmind Medicine's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clearmind Medicine COGS-to-Revenue Chart

Clearmind Medicine Annual Data

Trend

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

COGS-to-Revenue

Get a 7-Day Free Trial

Clearmind Medicine Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
COGS-to-Revenue	Get a 7-Day Free Trial															-	-	-	-	-

Clearmind Medicine COGS-to-Revenue Calculation

Clearmind Medicine's COGS to Revenue for the fiscal year that ended in Oct. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

Clearmind Medicine's COGS to Revenue for the quarter that ended in Jan. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

Clearmind Medicine (NAS:CMND) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Clearmind Medicine's Gross Margin % for the three months ended in Jan. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0 / 0
	=	N/A %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Clearmind Medicine COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Clearmind Medicine's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Clearmind Medicine (Clearmind Medicine) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clearmind Medicine Inc (NAS:CMND) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

CWY0:Germany CWY0:Germany CMND:Canada

Address

101-1220 West 6th Avenue, Vancouver, BC, CAN, V6H 1A5

Website

https://www.clearmindmedicine.com

Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.